HighTower Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-27,431
Closed -$4.86M 2583
2020
Q1
$4.86M Buy
27,431
+2,039
+8% +$384K 0.03% 458
2019
Q4
$4.85M Buy
25,392
+324
+1% +$58.4K 0.03% 554
2019
Q3
$4.22M Sell
25,068
-77,380
-76% -$12.6M 0.02% 623
2019
Q2
$17.2M Sell
102,448
-38,345
-27% -$5.31M 0.1% 213
2019
Q1
$20.5M Buy
140,793
+48,828
+53% +$7.08M 0.14% 159
2018
Q4
$12.3M Sell
91,965
-40,783
-31% -$6.69M 0.09% 220
2018
Q3
$25.3M Buy
132,748
+29,075
+28% +$5.34M 0.18% 109
2018
Q2
$17.4M Sell
103,673
-6,991
-6% -$1.12M 0.14% 165
2018
Q1
$18.7M Buy
110,664
+47,607
+75% +$7.99M 0.16% 133
2017
Q4
$10.3M Sell
63,057
-19,508
-24% -$3.5M 0.08% 259
2017
Q3
$16.8M Sell
82,565
-8,532
-9% -$1.98M 0.14% 151
2017
Q2
$22.1M Buy
91,097
+21,482
+31% +$5.05M 0.2% 109
2017
Q1
$16.6M Buy
69,615
+10,090
+17% +$2.35M 0.16% 128
2016
Q4
$12.5M Buy
59,525
+18,709
+46% +$3.88M 0.14% 161
2016
Q3
$9.42M Buy
40,816
+6,474
+19% +$1.58M 0.11% 194
2016
Q2
$7.94M Sell
34,342
-7,096
-17% -$1.64M 0.1% 221
2016
Q1
$11.1M Sell
41,438
-702
-2% -$201K 0.04% 178
2015
Q4
$13.2M Buy
42,140
+10,482
+33% +$3.12M 0.16% 142
2015
Q3
$8.62M Buy
31,658
+8,751
+38% +$2.69M 0.11% 193
2015
Q2
$6.99M Sell
22,907
-522
-2% -$156K 0.11% 194
2015
Q1
$6.98M Buy
23,429
+3,185
+16% +$908K 0.1% 217
2014
Q4
$5.21M Buy
20,244
+729
+4% +$182K 0.08% 269
2014
Q3
$4.71M Sell
19,515
-7,693
-28% -$1.72M 0.08% 280
2014
Q2
$6.07M Buy
27,208
+14,094
+107% +$2.92M 0.11% 212
2014
Q1
$2.7M Sell
13,114
-2,592
-17% -$513K 0.05% 416
2013
Q4
$2.64M Buy
15,706
+240
+2% +$37.5K 0.05% 379
2013
Q3
$2.23M Sell
15,466
-813
-5% -$108K 0.06% 389
2013
Q2
$2.06M Buy
+16,279
New +$1.84M 0.06% 388

Other funds holding AGN

HighTower Advisors's AGN Position: Q2 2020 in Review

HighTower Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 27,431 shares — an estimated $4.86M sold.

HighTower Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $25.3M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • HighTower Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • HighTower Advisors sold 27,431 Allergan plc shares in Q2 2020, an estimated $4.86M.
  • HighTower Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • HighTower Advisors's Allergan plc position peaked at $25.3M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on HighTower Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.